← Insider buys
RCUS

Arcus Biosciences, Inc. · Healthcare

General Counsel Carolyn C. Tang sold $78K of Arcus Biosciences, Inc.

Sold$77,582
$30.75Price
2,523Shares
−8%Stake

What RCUS did after the filing

Filed Dec 16Copier in Dec 19
The stock from Mon, Dec 19 open, $30.65
−31.0%
S&P 500, same days
+8.7%

Measured over 30 trading days, to the Feb 2 close.

Traded Fri, Dec 16. Filed Fri, Dec 16, 4:42 PM ET, after the close. Returns use the Dec 19 open and the Feb 2 close. Not investment advice.